PodcastsCienciasThe Long Run with Luke Timmerman

The Long Run with Luke Timmerman

Timmerman Report
The Long Run with Luke Timmerman
Último episodio

193 episodios

  • The Long Run with Luke Timmerman

    Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases

    03/03/2026 | 1 h 5 min
    Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
  • The Long Run with Luke Timmerman

    Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery

    17/02/2026 | 1 h 8 min
    Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery by Timmerman Report
  • The Long Run with Luke Timmerman

    Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines

    22/01/2026 | 1 h 5 min
    Ron Renaud, CEO of Waltham, Mass.-based Kailera Therapeutics, on developing GLP-1 based medicines to help people lose weight and live healthier lives.
  • The Long Run with Luke Timmerman

    Ep192: Kate Haviland on Following the Science to Precision Immunology

    08/01/2026 | 1 h 26 min
    Kate Haviland, former CEO of Blueprint Medicines, on how the company transitioned to a precision immunology company and was acquired by Sanofi for $9.5 billion.
  • The Long Run with Luke Timmerman

    Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

    15/12/2025 | 1 h 7 min
    Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).

Más podcasts de Ciencias

Acerca de The Long Run with Luke Timmerman

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Sitio web del podcast

Escucha The Long Run with Luke Timmerman, Babbage from The Economist y muchos más podcasts de todo el mundo con la aplicación de radio.net

Descarga la app gratuita: radio.net

  • Añadir radios y podcasts a favoritos
  • Transmisión por Wi-Fi y Bluetooth
  • Carplay & Android Auto compatible
  • Muchas otras funciones de la app
Aplicaciones
Redes sociales
v8.7.2 | © 2007-2026 radio.de GmbH
Generated: 3/14/2026 - 3:02:49 AM